BioSyent to Present at LD Micro New York Investor Conference
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 04 2025
0mins
Should l Buy ?
Source: Yahoo Finance
Company Presentation: BioSyent Inc. will have its President and CEO, Mr. René Goehrum, presenting at the LD Micro Invitational XV Conference in New York City on April 10, 2025, and he will also be available for one-on-one investor meetings.
Company Overview: BioSyent is a profitable specialty pharmaceutical company listed on the TSX Venture Exchange, focused on acquiring innovative healthcare products that improve patient lives, with 11,254,638 common shares outstanding.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
